1. Pink Sheet

Armstrong Wants Extra Year To Develop Inhaler Without Epinephrine

 
• By Joe Cantlupe

Generic manufacturer Armstrong Pharmaceuticals is asking FDA to delay for a year until 2011 the agency's proposed rule that would force epinephrine-containing metered-dose inhalers off the market

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Pink Sheet